Cargando…

Environmental and genetic risk factors for MS: an integrated review

Recent findings have provided a molecular basis for the combined contributions of multifaceted risk factors for the onset of multiple sclerosis (MS). MS appears to start as a chronic dysregulation of immune homeostasis resulting from complex interactions between genetic predispositions, infectious e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waubant, Emmanuelle, Lucas, Robyn, Mowry, Ellen, Graves, Jennifer, Olsson, Tomas, Alfredsson, Lars, Langer‐Gould, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764632/ https://www.ncbi.nlm.nih.gov/pubmed/31392849 http://dx.doi.org/10.1002/acn3.50862

Ejemplares similares

Pregnancy does not modify the risk of MS in genetically susceptible women
por: Adams, Cameron J., et al.
Publicado: (2020)

Organic solvents and MS susceptibility: Interaction with MS risk HLA genes
por: Hedström, Anna Karin, et al.
Publicado: (2018)

Low fish consumption is associated with a small increased risk of MS
por: Hedström, Anna Karin, et al.
Publicado: (2020)

Clinical predictors of early second event in patients with clinically isolated syndrome
por: Mowry, Ellen M., et al.
Publicado: (2009)

Modifiable environmental exposure and risk of rheumatoid arthritis—current evidence from genetic studies
por: Jiang, Xia, et al.
Publicado: (2020)

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics
por: Langer-Gould, Annette, et al.
Publicado: (2018)

Age at Menarche and Risk of Multiple Sclerosis: Current Progress From Epidemiological Investigations
por: Jiang, Xia, et al.
Publicado: (2018)

Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology
por: Hedström, Anna Karin, et al.
Publicado: (2020)

Obesity's role in MS: An intervention target with possible interactions
por: Fitzgerald, Kathryn C., et al.
Publicado: (2020)

The increased risk of multiple sclerosis associated with HLA-DRB1*15:01 and smoking is modified by alcohol consumption
por: Hedström, Anna Karin, et al.
Publicado: (2021)

Alcohol Consumption and Risk of Common Autoimmune Inflammatory Diseases—Evidence From a Large-Scale Genetic Analysis Totaling 1 Million Individuals
por: Jiang, Xia, et al.
Publicado: (2021)

Rituximab, MS, and pregnancy
por: Smith, Jessica B., et al.
Publicado: (2020)

Distinct effects of obesity and puberty on risk and age at onset of pediatric MS
por: Chitnis, Tanuja, et al.
Publicado: (2016)

Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis
por: Hedström, Anna Karin, et al.
Publicado: (2021)

The COVID-19 pandemic and the use of MS disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2020)

Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study
por: Åkerstedt, Torbjörn, et al.
Publicado: (2023)

Low sun exposure increases multiple sclerosis risk both directly and indirectly
por: Hedström, Anna Karin, et al.
Publicado: (2019)

Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry
por: Chi, Calvin, et al.
Publicado: (2019)

Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report
por: Chitnis, Tanuja, et al.
Publicado: (2016)

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
por: Fitzgerald, Kathryn C., et al.
Publicado: (2021)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

Defining Benign/Burnt-Out MS and Discontinuing Disease-Modifying Therapies
por: McFaul, Derek, et al.
Publicado: (2021)

Biosensor vital sign detects multiple sclerosis progression
por: Krysko, Kristen M., et al.
Publicado: (2020)

Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
por: Waubant, Emmanuelle
Publicado: (2006)

Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab
por: Razaz, Neda, et al.
Publicado: (2020)

High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies
por: Hedström, A K, et al.
Publicado: (2016)

Smoking and multiple sclerosis susceptibility
por: Hedström, Anna Karin, et al.
Publicado: (2013)

COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls
por: Longinetti, Elisa, et al.
Publicado: (2022)

High-dose vitamin D(3) supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
por: Cassard, Sandra D., et al.
Publicado: (2023)

A randomized controlled phase II trial of riluzole in early multiple sclerosis
por: Waubant, Emmanuelle, et al.
Publicado: (2014)

Hospital diagnosed pneumonia before age 20 years and multiple sclerosis risk
por: Smith, Kelsi A, et al.
Publicado: (2020)

Association between exposure to combustion-related air pollution and multiple sclerosis risk
por: Hedström, Anna Karin, et al.
Publicado: (2023)

Consumption of red meat, genetic susceptibility, and risk of LADA and type 2 diabetes
por: Löfvenborg, Josefin E., et al.
Publicado: (2020)

Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS
por: Mowry, Ellen M., et al.
Publicado: (2013)

Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery
por: Mowry, Ellen M., et al.
Publicado: (2013)

Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression
por: Wu, Jing, et al.
Publicado: (2023)

Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder
por: Ciplea, Andrea Ines, et al.
Publicado: (2020)

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG
por: Waubant, Emmanuelle, et al.
Publicado: (2019)

A pilot study of oxidative pathways in MS fatigue: randomized trial of N‐acetyl cysteine
por: Krysko, Kristen M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5tsmupbneskhp5i9enndevg67a